Expression of insulin-like growth factor-1 receptor (IGF-1R) and p27(Kip1) in melanocytic tumors: A potential regulatory role of IGF-1 pathway in distribution of p27(Kip1) between different cyclins

Growth Factors

Volumn 17, Issue 3, 2000, Pages 193-202

  Kanter Lewensohn, Lena ^a   Dricu, Anica ^a   Girnita, Leonard ^a   Wejde, Johan ^a   Larsson, Olle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cyclins; IGF 1R; Melanoma cells; p27(Kip1)

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN E; CYCLINE; PROTEIN P27; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TUNICAMYCIN;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL SURFACE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MELANOMA; PRIORITY JOURNAL;

EID: 0033974692     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.3109/08977190009001068     Document Type: Article

References (40)

1. Alessandrini, A., Chiaur, D.S. and Pagano, M. (1997) Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 11, 342-345.
2. Baserga, R. (1995) The insulin-like growth factor-1 receptor: a key to tumor growth? Cancer Res. 55, 249-252.
3. Baserga, R. (1997) The IGF-1 receptor and cancer. Endocrine 7(1), 99-102.
4. Baserga, R., Hongo, A., Rubini, M., Prisco, M. and Valentinis, B. (1997) The IGF-1 receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta 1332, 105-126.
5. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72, 248-254.
6. Carlberg, M., Dricu, A., Blegen, H., Wang, M., Hjertman, M., Zickert, P., Höög, A. and Larsson, O. (1996) Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface: evidence for a new link between 3-hydroxy-3-methylglutaryl-Coenzyme A reductase and cell growth. J. Biol. Chem. 271, 17453-17462.
7. Kip1 protein: prognostic implications in primary breast cancer. Nature Med. 3, 227-230.
8. Dricu, A., Carlberg, M., Wang, M. and Larsson, O. (1997a) Inhibition of N-linked glycosylation using tunicamycin causes cell death in malignant cells: role of down-regulation of the insulin-like growth factor-1 receptor in induction of apoptosis. Cancer Res. 57, 543-548.
9. Dricu, A., Wang, M., Hjertman, M., Malec, M., Blegen, H., Wejde, J., Carlberg, M. and Larsson, O. (1997b) Mevalonate-regulated cell growth in human tumor cells: role of glycosylation of the IGF-1 receptor, prenylation of Ras and expression av c-Myc. Glycobiology, 7, 625-633.
10. Dricu, A., Kanter, L., Wang, M., Nilsson, G., Hjertman, M., Wejde, J. and Larsson, O. (1999) Expression of the insulin-like growth factor 1 receptor (IGF-1R) in breast cancer cells: evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway. Glycobiology 9, 571-579.
11. Esposito, V., Baldi, A., De Luca, A., Groger, A.M., Loda, M., Giordano, G.G., Caputi, M., Baldi, F., Pagano, M. and Giordano, A. (1997) Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res. 57, 3381-3385.
12. (Kip1) and degree of malignancy in human breast and colorectal cancers. Proc. Natl. Acad. Sci. USA 94, 6380-6385.
13. Gammeltoft, S. (1990) Peptide hormone action. A practical approach. In Peptide Hormone Receptors, K. Siddle and J.C. Hutton, eds. Oxford University Press, Oxford, pp. 1-41.
14. Gray-Bublin, J., Rao, S. and Keyomarsi, K. (1997) Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion. Cancer Res. 57, 604-609.
15. Halaban, R. (1996) Growth factors and melanomas. Semin. Oncology 23, 673-681.
16. Hengst, L., Dulic, V., Slingerland, J.M., Lees, E. and Reed, S.I. (1994) A cell-cycle regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91, 5291-5295.
17. Kanter-Lewensohn, L., Dricu, A., Wang, M., Wejde, J., Kiessling, R. and Larsson, O. (1998) Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a potential therapeutic target. Melanoma Res. 8, 389-397.
18. Katayose, Y., Kim, M., Rakkar, A.N.S., Li, Z., Cowan, K.H. and Seth, P. (1997) Promoting apoptosis: a novel activity associated with the cyclin dependent kinase inhibitor p27. Cancer Res. 57, 5441-5445.
19. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
20. Larsson, O. (1996) HMG-CoA reductase inhibitors: role in normal and malignant cells. Crit. Rev. Oncol./Hematol. 22, 197-212.
21. Loda, M., Cukor, B., Tam, S.W., Lavin, P., Fiorentino, M., Draetta, G.F., Jessup, J.M. and Pagano, M. (1997) Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med. 3, 231-234.
22. Morgan, D.O. (1997) Cyclin dependent kinases: engines, clocks and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261-291.
23. Mori, M., Mimori, K., Shiraishi, T., Tanaka, S., Ueo, H., Sugimachi, K. and Akiyoshi, T. (1997) p27 expression and gastric carcinoma. Nature Med. 3, 593.
24. Mouriaux, F., Casagrande, F., Pillaire, M.J., Manenti, S., Malecaze, F. and Darbon, J.M. (1998) Different expression of G1 cyclins and cyclin-dependent inhibitors in normal and transformed melanocytes. Invest. Ophthalmol. Vis. Sci. 39, 876-884.
25. Poon, R.Y.C., Toyoshima, H. and Hunter, T. (1995) Redistribution of the cdk inhibitor p27 between different cyclin-cdk complexes in the mouse fibroblast cell cycle and in cells arrested with Lovastatin or ultraviolet irradiation. Mol. Biol. Cell 6, 1197-1213.
26. Porter, P.L., Malone, K.E., Heagerty, P.J., Alexander, G.M., Gatti, L.A., Firpo, E.J., Daling, J.R. and Roberts, J.M. (1997) Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222-225.
27. Resnicoff, M., Coppola, D., Sell, C., Rubin, R., Ferrone, S. and Baserga, R. (1994) Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res. 54, 4848-4850.
28. Resnicoff, M., Burgaud, J.-L., Rotman, H.L., Abraham, D. and Baserga, R. (1995a) Correlation between apoptosis, tumorigenesis and levels of insulin-like growth factor 1 receptors. Cancer Res. 55, 3739-3741.
29. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H.L., Kajstura, J., Rubin, R., Zoltick, P. and Baserga, R. (1995b) The insulin-like growth factor receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55, 2463-2469.
30. Roberts, C.J., Koff, A., Polyak, K., Firpo, E., Collins, S., Ohtsubo, M, and Massagué, J. (1994) Cyclins, cdks, and cyclin kinase inhibitors. Cold Spring Harbor Symposia on Quantitative Biology 59, 31-38.
31. Sherr, C.J. (1994) G1 phase progression: cycling on cue. Cell 79, 551-555.
32. Sherr, C.J and Roberts, J. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Devel. 9, 1149-1163.
33. Singh, S.P., Lipman, J., Goldman, H., Ellis Jr., F.H., Aizenman, L., Cangi, M.G., Signoretti, S., Chiaur, D.S., Pagano, M. and Loda, M. (1998) Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res. 58, 1730-1735.
34. Slingerland, J.M., Hengst, L., Pan, C., Alexander, D., Stampfer, M. and Reed, S. (1994) A novel inhibitor of cyclin-cdk activity detected in TGF-β-arrested epithelial cells. Mol. Cell. Biol. 14, 3683-3694.
35. Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene 15, 2991-2997.
36. Waechter, C.J. and Lennarz, W.J. (1976) The role of polyprenol-linked sugars in glycoprotein synthesis. Ann. Rev. Biochem. 45, 95-112.
37. Werner, H. and Le Roith, D. (1997) The insulin-like growth factor-1 receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis. Oncogenesis 8, 71-92.
38. Werner, H. (1998) Dysregulation of the type 1 IGF receptor as a paradigm in tumor progression. Mol. Cell. Endocrinol. 141, 1-5.
39. Cip1/Waf1 on growth and differentiation in human colon carcinoma cells. Oncogene 18, 103-115.
40. Yang, R.M., Naitoh, J., Murphy, M., Wang, H.J., Phillipson, J., de Kernion, J.B., Loda, M. and Renter, R.E. (1998) Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J. Urol. 159, 941-945.